Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Vertex

Watch These Leaders With Earnings Due, Buy Zones In Focus

With earnings due, IBD Leaderboard stocks like Eli Lilly, Vertex and Ollie's test bases, breakouts and buy zones.

Investors Business Daily

Dow Jones Falls As Boeing Surges; Chinese EV Stocks Rise On Deliveries

The Dow Jones Industrial Average fell 150 points Monday, as Boeing surged on 787 Dreamliner news. Chinese EV stocks rose on July deliveries.

Investors Business Daily

Dow Jones Reverses Higher Despite Hot Inflation Report; Amazon, Apple Rally On Earnings

The Dow Jones Industrial Average reversed higher Friday on a hot inflation report. Amazon and Apple rallied on strong results.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Rises As GDP Signals Recession; Meta Slides On Earnings; Apple Earnings Due

The Dow Jones Industrial Average rose Thursday, as tech giant Meta Platforms slid on weak earnings results. Apple earnings are due next.

Investors Business Daily

Dow Jones Rises Ahead Of Fed Decision; Alphabet, Microsoft Earnings Miss

The Dow Jones Industrial Average rallied 130 points Wednesday ahead of the Federal Reserve's interest-rate decision.

Investors Business Daily

Dow Jones Falls As Walmart Plunges On Profit Warning; Alphabet, Microsoft Earnings Due

The Dow Jones Industrial Average fell Tuesday, as Walmart plunged on a profit warning. Alphabet and Microsoft earnings are due late.

Investors Business Daily

Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

CRISPR, 10 Years On: Learning to Rewrite the Code of Life

Ten years ago this week, Jennifer Doudna and her colleagues published the results of a test-tube experiment on bacterial genes. When the study came out in the journal Science on June 28, 2012, it did not make headline news. In fact, over the next few weeks, it did not make…

Asharq Al-Awsat

The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks

The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.

Investors Business Daily

Biotech Can't Conquer the Lungs. Will These Stocks Succeed?

The lungs have evolved to keep things out. Can these biotech stocks get drugs in?

The Street

Medical Sector Leads New Buys By Top Funds While Big Mac Joins Big Oil

As tech titans like Apple and Nvidia get shunned again, the best mutual funds focus on Big Pharma and biotech stocks.

Investors Business Daily

Biotechs Say ESG Is Core To Their Mission; Do Investors Believe Them?

The biotech industry is trying to catch the ESG investing bug. But that doesn't mean investors are giving it credit, executives say.

Investors Business Daily

Why Top-Notch Biotech Stock Vertex Pharmaceuticals Just Hit A Record

The FDA cleared Vertex to restart testing a diabetes treatment, and VRTX stock jumped to a fresh high Wednesday.

Investors Business Daily

Vertex, WWE, KO Stock Among 25 Names On IBD Breakout Stocks Index

As the market regroups, 25 names — including Vertex, WWE, Li Auto and KO stock — make the IBD Breakout Stocks Index.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

4 "Strong Buy" Biotech Stocks to Add to Your Watchlist

As the Biotech industry’s role in finding cures for chronic diseases and critical conditions is expected to keep attracting investors’ attention, it could be wise to scoop up shares of the fundamentally-strong biotech companies Vertex Pharmaceuticals (VRTX), United Therapeutics (UTHR), Amgen (AMGN), and Sino Biopharmaceutical (SBHMY) because of their solid…

Investors Business Daily

Dow Jones Futures Fall: Inflation, Jobs Data Could Be Catalyst For Ailing Market Rally

The stock market rally searched for direction Wednesday. Jobless claims and inflation data are on tap.

StockNews.com

VRTX is the Growth Stock of the Week

The market is in a tough place with stubbornly high inflation, a hawkish Fed, and a slowing economy. These conditions are tough for most stocks, but pharmaceuticals are an exception. One of the top companies in the space is Vertex Pharmaceuticals (VRTX). Read on to find out why it's our…

Investors Business Daily

Dow Jones Futures Rise After Nasdaq Leads Uneven Market Rally

The Nasdaq rose strongly Thursday, but is this would-be bull just messing with investors?

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Dow Jones Futures: New Market Rally Struggles For Direction; 5 Stocks Near Buy Points

The market rally rebounded from losses but gains faded. Five stocks from a hot sector are near buy points.

Investors Business Daily

Dow Jones Rises, Techs Lead As Fed Chief Powell Minimizes Recession Risks

Stocks turned mixed as Fed chief Jerome Powell minimized recession risks before Congress. But crude oil and bond yields tumbled.

Investors Business Daily

Biotech Stock United Therapeutics Revives Breakout, Retakes Buy Zone

Biotech stock United Therapeutics joins peers Vertex and Harmony Biosciences on the Breakout Stocks Index as it reenters a buy zone.

Investors Business Daily

Dow Jones Futures Jump, Bitcoin Above $20,000; Beware The Bear Market

Futures rose as Bitcoin rebounded. It's a bear market, so stay safe. Tesla rival BYD is among a few stocks setting up.

Investors Business Daily

Do Crispr And Vertex Have A 'Functional Cure' For Blood Diseases?

Crispr Therapeutics could have a "functional cure" for two inherited blood diseases, analysts said Monday, but CRSP stock plummeted.

Benzinga

Looking Into Vertex's Return On Capital Employed

According to data from Benzinga Pro, during Q1, Vertex's (NASDAQ:VERX) reported sales totaled $114.98 million. Despite a 46.73% increase in earnings, the company posted a loss of $334.00 thousand.

Investors Business Daily

Dow Jones Dives On Hot Inflation Report; DocuSign Plunges 23% On Earnings

The Dow Jones Industrial Average dived Friday on a hot inflation report in the wake of Thursday's stock market sell-off. DocuSign plunged on earnings.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations